Renal disease Market Booming Worldwide with Latest Trend and Future Scope by 2027
Research Reports
Mar 18, 2022
Market Overview
Renal disease or kidney disease is a damage or disease of kidney which causes partial or complete loss of its functioning leading to kidney failure. Some of the leading causes of renal disease include long term usage of analgesics, medical conditions like diabetes and high blood pressure, heredity, genetic mutation, diet and life style. According to the National Centre of Healthcare Statistics, 2015, 4.9 million adults in the U.S are diagnosed with kidney diseases representing 2% of the adult population causing 15.5 deaths per 100,000 individuals that makes kidney diseases the 9th largest cause of mortality in the U.S. According to National kidney foundation, Inc., 10% of the world’s population is suffering from Chronic Kidney Diseases (CKD).
Market Research Future (MRFR) has recently published a report averring that the global renal disease market will witness a is expected to grow at the CAGR of 6.3% during thein the forecast period (of 2017-2023). The need forof novel treatments to improve the quality of life of patients is growing at a rapid pace. The focus of healthcare sector and Pharmaceutical industries on putting forth innovative initiatives to meet the increasing market demand for better treatments is fuelling the growth of the global renal disease market. In addition, rising prevalence ofThe hike in risk factors such as alcoholism, obesity, diabetes and other conditions has also increased the risk of renal diseases. is driving the global renal disease market. Advancement in technology for better diagnosis and treatment of these diseases is further stimulating the market growth.
Sample Report : https://www.marketresearchfuture.com/sample_request/3167
Global Renal Disease Market: Segmentation:
The global renal disease market has been segmented on the basis of types, diagnosis and treatment. On the basis of type, the market isit is further segmented into acute kidney problems, chronic kidney diseases and others. The acute kidney problem segment is further s are sub-segmented into pre-renal, post-renal and renal. On the basis of diagnosis, the market is segmented intoit is classified into bBlood test which includes( bBlood uUrea nNitrogen (BUN), sSerum cCreatinine, gGlomerular fFiltration rRate (GFR), fFasting blood glucose test),; uUrine test (est that includes pProtein urine test, uUrinalysis, cCreatinine clearance test and mMicro albuminuria test),; iImaging test ( that includes uUltrasound and CT scan and kidney sSample test) that is carried out by removing a tissue sample of kidney for testing. On the basis of treatment, market isit is further segmented into mMedication such as( high blood pressure medication, medication for anemia, medications to lessen swelling and medication for protection of bones); hemodialysis and peritoneal dialysis,; sSurgical procedures (that includes nephrectomy and radial nephrectomy, nephron-sparing surgery (NSS), extracorporeal shock wave lithotripsy (ESWL), nephrolithotripsy and others),; kKidney transplant (such as deceased-donor kidney transplant, living-donor kidney transplant, pre-emptive kidney transplant) and; diet and more.
Based on regionRegionally, the global renal disease market was segmented into has captured North America, Europe, Asia-Pacific, and the Middle-East and Africa (MEA).
Regional analysis:
With respect to the strong economic conditions of the region and rapid adoption of advanced technology, North America is considered as the largest market for global renal disease and is believed to lead over the upcoming years. The increasing rate of diagnosed cases of diabetes and obesity in this region is fuelling the global renal disease market in North America.
Europe is the second largesteading marketregion for in the global renal disease market and here, Western Europe is dominating the European market. The increasing number of kidney cancer patients in thisis region is generating the need forof quality treatment for the patients which is supporting the growth of driving the Europe renal diseasean market towards growth.
The noteworthy expansion of medical and healthcare industry in Asia-Pacific is predicted to aid the growth of renal disease market in this region. Due to the lack of awareness, political conditions and poor per capita income of the region, the global renal disease market is likely to witness sluggish growth considered to be constrained in the Middle East and Africa (MEA).
Access Report Details @ https://www.marketresearchfuture.com/reports/renal-disease-market-3167
Competitive analysis:
The healthcare and pharmaceutical industry is growing in a brisk pacerate, increasing the competition amongof the leading companies in the to make their mark on the global renal disease market. The advancement in technology and high acceptance of vital and effective treatments is driving the market to astral levels. Some of the key players in global renal disease market includeare Abbott (US), Shire Pharmaceuticals Limited (Republic of Ireland), Amgen Inc. (US), Baxter (US), NephroGenex, Inc. (US), Bristol-Myers Squibb Company (US), Novartis AG (Switzerland), Keryx Biopharmaceuticals, Inc. (US), Pfizer Inc.(US) and Sanofi (France).
Intended Audience:
- Medical Research laboratories.
- Renal disease medicines and device manufacturers.
- Market Research and Consulting Service Providers.
- Research and Development (R&D) Companies.
- Renal disease medicine suppliers.
- Potential Investors.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Get More Related Reports:
https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557
https://www.marketresearchfuture.com/reports/jaw-surgery-market-5077
https://www.marketresearchfuture.com/reports/soft-tissue-sarcoma-market-5304
Contact Information:
Contact: Market Research Future® 99 Hudson Street,5Th Floor New York, New York 10013 United States of America Phone: +1 628 258 0071(US)
Tags:
PR-Wirein, Wire, Research Newswire, English